Showing 1 - 7 results of 7 for search 'Eva Kassi', query time: 0.04s Refine Results
  1. 1
    Ex Vivo Tools and Models in MASLD Research

    Ex Vivo Tools and Models in MASLD Research by Rallia-Iliana Velliou, Eirini Giannousi, Christiana Ralliou, Eva Kassi, Antonios Chatzigeorgiou

    Published 2024-11-01
    Get full text
    Article
  2. 2
    A Critical Appraisal of Contemporary and Novel Biomarkers in Pheochromocytomas and Adrenocortical Tumors

    A Critical Appraisal of Contemporary and Novel Biomarkers in Pheochromocytomas and Adrenocortical Tumors by Marina Tsoli, Kosmas Daskalakis, Eva Kassi, Gregory Kaltsas, Apostolos V. Tsolakis

    Published 2021-06-01
    Get full text
    Article
  3. 3
    The Diagnostic, Prognostic and Therapeutic Role of miRNAs in Adrenocortical Carcinoma: A Systematic Review

    The Diagnostic, Prognostic and Therapeutic Role of miRNAs in Adrenocortical Carcinoma: A Systematic Review by Chrysoula Mytareli, Danae A. Delivanis, Fani Athanassouli, Vassiliki Kalotychou, Marina Mantzourani, Eva Kassi, Anna Angelousi

    Published 2021-10-01
    Get full text
    Article
  4. 4
    Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review

    Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review by Narjes Nasiri-Ansari, Theodoros Androutsakos, Christina-Maria Flessa, Ioannis Kyrou, Gerasimos Siasos, Harpal S. Randeva, Eva Kassi, Athanasios G. Papavassiliou

    Published 2022-08-01
    Get full text
    Article
  5. 5
    High Prevalence of Primary Aldosteronism in Patients with Type 2 Diabetes Mellitus and Hypertension

    High Prevalence of Primary Aldosteronism in Patients with Type 2 Diabetes Mellitus and Hypertension by Ernestini Tyfoxylou, Nick Voulgaris, Chris Gravvanis, Sophia Vlachou, Athina Markou, Labrini Papanastasiou, Nikolaos Tentolouris, Eva Kassi, Gregory Kaltsas, George P. Chrousos, George P. Piaditis

    Published 2022-09-01
    Get full text
    Article
  6. 6
    Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe

    Anti-osteoporotic treatments in the era of non-alcoholic fatty liver disease: friend or foe by Maria Eleni Chondrogianni, Maria Eleni Chondrogianni, Ioannis Kyrou, Ioannis Kyrou, Ioannis Kyrou, Ioannis Kyrou, Ioannis Kyrou, Ioannis Kyrou, Ioannis Kyrou, Theodoros Androutsakos, Christina-Maria Flessa, Evangelos Menenakos, Kamaljit Kaur Chatha, Kamaljit Kaur Chatha, Kamaljit Kaur Chatha, Yekaterina Aranan, Yekaterina Aranan, Athanasios G. Papavassiliou, Eva Kassi, Eva Kassi, Harpal S. Randeva, Harpal S. Randeva, Harpal S. Randeva, Harpal S. Randeva

    Published 2024-03-01
    Get full text
    Article
  7. 7
    Endocrine‐related adverse events associated with immune‐checkpoint inhibitors in patients with melanoma

    Endocrine‐related adverse events associated with immune‐checkpoint inhibitors in patients with melanoma by Eva Kassi, Anna Angelousi, Nikolaos Asonitis, Panagiotis Diamantopoulos, Amalia Anastasopoulou, George Papaxoinis, Michalis Kokkinos, Ilias Giovanopoulos, Georgios Kyriakakis, Fotini Petychaki, Akrivi Savelli, Olga Benopoulou, Helen Gogas

    Published 2019-11-01
    Get full text
    Article

Search Tools: